Risk of malignancy in myasthenia gravis patients exposed to azathioprine therapy for a median period of 3 years | Rawoot | South African Medical Journal

Scientific letters

Risk of malignancy in myasthenia gravis patients exposed to azathioprine therapy for a median period of 3 years

A Rawoot, F Little, J M Heckman

Authors' affiliations

A Rawoot, HMPG

F Little,

J M Heckman,

Full Text

PDF (228KB)

Cite this article

South African Medical Journal 2006;96(12):1249.

Article History

Date submitted: 2008-02-21
Date published: 2008-02-21

Article Views

Abstract views: 2004
Full text views: 566

Comments on this article

*Read our policy for posting comments here

The South African Medical Journal | Online ISSN: 2078-5135 | Print ISSN: 0256-9574 | © 2014 Health & Medical Publishing Group

This journal is protected by a Creative Commons Attribution - NonCommercial Works License (CC BY-NC 4.0) | Read our privacy policy.

Our Journals: South African Medical Journal | African Journal of Health Professions Education | South African Journal of Bioethics and Law | South African Journal of Child Health | Southern African Journal of Critical Care | South African Journal of Obstetrics and Gynaecology |